Verify logo

Who’s impacted by substandard and falsified pharmaceuticals? Potentially everyone.

All over the world, drug manufacturers put time, effort, and money into making sure their products meet the regulatory requirements of a host of different regions. Yet substandard and falsified products still find their way into the market. Somewhere along the line the supply chain is disrupted and low-quality products are introduced.

  • Resolution

    How can we resolve this problem?

    ARTiFACTS Verify enables quality monitoring across the entire supply chain: from manufacturers’ shipping locations all the way through to patient interaction for comprehensive post-market surveillance.

  • Technologies

    What technology do we use?

    We help our partners - laboratories, scientific institutions, regulatory bodies - create an irrefutable chain of custody using Web 3.0 technologies for fast and effective monitoring.

How it works

Tethered to analytical testing labs, ARTiFACTS Verify gives stakeholders a secure chain of custody using a distributed ledger for all data relating to a suspected falsified or substandard products. This provides an iron-clad and essential reference when proving and defending results for immediate action by distributors, manufacturers, and regulatory agencies.

Short timeline
  • Shortening the timeline between sample collection, screening, and testing

  • Timeline item

    1. In-field collection of samples

    E.g. from a pharmacy, hospital, or online.

  • Timeline item

    2. In-field assessment

    Chromatographic chemical screens taken in the field using low-cost paper-based tools giving first indication of tainted products.

  • Timeline item

    3. Samples batched, shipped, and routed to labs

    Samples sent to leading labs based in academic institutions or commercial entities

  • Timeline item

    4. Full analysis

    Samples analyzed by highly trained staff using rigorously tested equipment suitable for each drug-type.

  • STimeline item

    5. Results collected, assessed, and reported directly to stakeholders to action

    Stakeholders - including regulatory bodies - can then take mitigating action

Who do we partner with?

  • University research departments and laboratories
  • Government and NGO public health regulatory authorities
  • Private / commercial laboratories
  • Manufacturers
  • Distributors
  • Philanthropies / charities in the public health space